You are here: CTSPedia>Main Web>WikiUsers>LuisVelez (27 Aug 2015, RegistrationAgent?)EditAttach
create new tag
, view all tags, tagging instructions

My Links

  • BeginnersStartHere - view a short introductory presentation on Foswiki for beginners
  • WelcomeGuest - starting points on Foswiki
  • UsersGuide - complete Foswiki documentation, Quick Start to Reference
  • Sandbox - try out Foswiki on your own

My Personal Data

Note: if personal data is being stored using a secret database, then it is only visible to the user and to administrators.


My Personal Preferences

Uncomment preference settings to activate them (remove the #-sign). Help and details on preference settings are available in DefaultPreferences.

  • Show tool-tip topic info on mouse-over of WikiWord links, on or off:
    • #Set LINKTOOLTIPINFO = off

Related Topics

UserForm edit

FirstName Luis
LastName Velez
Title Candidate PhD? in Pharmacoepidemiology
OrganizationName University of Basel
Location Basel
Country Switzerland
OrganizationDescription Academic/Educ - Not a CTSA Member
PrimaryAreaOfExpertise Epidemiologist
Education MD, MSc in Pharmacovigilance, candidate PhD? Pharmacoepidemiology
Degree Medical Doctor (Doctorate)
Publications Velez-Nandayapa L. Unintended central nervous system risks with dextromethorphan in different indications. Preliminary results; systematic review and meta-analysis of randomised clinical trials. The 15th Annual Meeting of the International Society of Pharmacovigilance (ISoP? 2015), in Prague, Czech Republic 27-30th of October 2015. Abstract confirmation ISOP-020. Accepted for poster presentation on 16July2015. Velez-Nandayapa L., DeVore? L. The risk of urinary tract infections with the use of dextromethorphan in different indications. Results from a systematic review and meta-Analysis of Randomised Clinical Trials. International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) annual meeting - Boston, Massachusetts August 2015. Abstract confirmation 1096. Accepted for poster presentation on 29Apr2015. Velez-Nandayapa L., Bhattacharya A., Parikh C. The risk of serious infections with the use of rituximab in rheumatoid arthritis. Results from a meta-analysis of randomized clinical trials. Federation of European Microbiological Societies (FEMS) Congress, June 2015 Maastricht, Holland. Abstract confirmation FEMS-3137. Accepted for poster presentation on 25Feb2015. Harmsen, H.J., Hensbeek van, I., and the Mirtazapine Study Group. A naturalistic study of mirtazapine in the Mexican psychiatric practice. The International Journal of Neuropsychopharmacology 3(suppl 1), S253; 2000. Bill, P.A., Vigonius, U., Pohlman, H., and the International Oxcarbazepine Trial Group. A double-blind controlled clinical Trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Research 27; 1997: 195-204.
Presentations The same for the posters
Awards MSc in Pharmacovigilance with distintion
Patents None
Topic revision: r1 - 27 Aug 2015 - 09:44:56 - RegistrationAgent?
Copyright & by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding CTSPedia? Send feedback